Searching for potential biomarkers that can be used as biomarkers for diagnosing ankylosing spondylitis.

J. Bons, D. van der Heijde, F.G. Bouwman, E.C.M. Mariman, M.P. van Dieijen-Visser, R. Landewé, J. van der Linden, K.W. Wodzig

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)


Aim: Ankylosing spondylitis (AS) is a chronic systemic inflammatory rheumatic disorder that primarily affects the axial skeleton. To date there is no satisfactory biomarker for diagnosis or prognosis of AS. This study is focused on detection of potential biomarkers for the diagnosis of AS using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) with the ultimate goal of developing a progression biomarker for AS. Materials
Original languageEnglish
Pages (from-to)23-30
JournalBiomarkers in Medicine
Issue number1
Publication statusPublished - 1 Jan 2008

Cite this